This page contains a Flash digital edition of a book.
years) and 4 grossly normal colon (2 female, 2 male, av- erage age 65 years) FFPE blocks were purchased (Advanced Tissue Services). mCRC samples were classi- fied as KRAS mutation posi- tive by the vendor. Samples were prepared using stan- dard protocols (QIAGEN)


• Droplet Digital PCR (ddP- CR™) was performed on 1–5 µl per sample per well using either a multiplexed KRAS G12/G13 Assay or val- idated PrimePCR™ ddPCR Mutation Assay for one of seven individual KRAS mu- tations (G12D, G12V, G13D, G12A, G12C, G12R, G12S, Bio-Rad)


• Positive mutation refer- ences were from Horizon Diagnostics, and negative controls were wild-type–only from Promega Corporation (female genomic DNA [gDNA]). Statistical signifi- cance was determined using 95% confidence intervals


Conclusions


• We have demonstrated sensitive and precise detec- tion (less than 1%, single re- action) of multiple actionable KRAS mutations in FFPE samples from patients with colorectal cancer


• Concordance between du- plex- and multiplex-based detection is excellent


• Droplet Digital PCR provides a simple and robust workflow for mutation detection of patient samples in a rapid and cost-effective manner • UDG treatment of FFPE DNA reduces the false positives generated by deaminated C>T transitions caused by formalin fixation


References


Do H and Dobrovic A (2012). Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase. Oncotarget 3, 546–558.


Faulkner NE et al. KRAS mutation analyses of more than 16,500 colorectal carcinomas. Poster presented at: 2010 ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer; October 18–20, 2010; Hollywood, Florida [unpublished data].


Visit bio-rad.com/web/ddPCRKRAS for more information. FAM is a trademark of Applera Corporation. BioTechniques 58:270-271 (May 2015) doi 10.2144/000114293


Vol. 58 | No. 5 | 2015 271 www.BioTechniques.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68